Causaly, founded in 2018, builds an AIādriven platform that transforms lifeāscience research by accelerating data discovery, analysis, and decisionāmaking in drug discovery and development. Leveraging advanced naturalālanguage understanding and knowledgeāgraph technologies, the platform supports complex knowledge workflows from benchāside experiments to therapeutic launch. By bridging data silos and enabling rapid hypothesis generation, Causaly empowers pharmaceutical and biotechnology organizations to shorten development timelines and bring lifeāchanging therapies to market faster. The companyās culture values interdisciplinary collaboration, continuous innovation, and a commitment to using AI responsibly to unlock scientific insight.
Causaly is redefining how humans acquire knowledge and develop insights in biomedicine. Our AI-powered platform enables researchers and decision-makers to discover and interpret evidence from millions of scientific publications, clinical trials, regulatory documents, and other complex data sources in minutes. We are building the worldās most advanced biomedical knowledge platform, powered by a high-precision Knowledge Graph and GenAI capabilities.
Causaly, founded in 2018, builds an AIādriven platform that transforms lifeāscience research by accelerating data discovery, analysis, and decisionāmaking in drug discovery and development. Leveraging advanced naturalālanguage understanding and knowledgeāgraph technologies, the platform supports complex knowledge workflows from benchāside experiments to therapeutic launch. By bridging data silos and enabling rapid hypothesis generation, Causaly empowers pharmaceutical and biotechnology organizations to shorten development timelines and bring lifeāchanging therapies to market faster. The companyās culture values interdisciplinary collaboration, continuous innovation, and a commitment to using AI responsibly to unlock scientific insight.